Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OraSure OraQuick

This article was originally published in The Gray Sheet

Executive Summary

Rapid HIV-1 antibody test is deemed "approvable" by FDA pending resolution of "specific validation and control issues" detected during a recent agency inspection of the firm's manufacturing facilities, OraSure announces May 13. The test can detect HIV-1 antibodies in whole blood via a finger stick within 20 minutes (1"The Gray Sheet" May 6, 2002, p. 42). A market launch is slated for the second half of the year...

You may also be interested in...



OraSure License/Marketing Pact With Abbott To Aid OraQuick HIV Test Launch

OraSure Technologies' license of non-exclusive rights to certain test strip technology patents from Abbott appears to clear the way for a U.S. launch of OraSure's OraQuick rapid HIV-1 test, pending FDA approval

OraSure OraQuick HIV Blood Test Launch Expected In Latter Half Of 2002

OraSure anticipates FDA approval of its OraQuick fingerstick whole blood rapid HIV-1 test by mid-May

APACMed 2020: Healthineers Evolves Therapy Remit And Makes All Asia An Equal Priority

Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel